Skip to content
BillionaireList

Rank 527 of 3,368

Massimiliana Landini Aleotti net worth

Massimiliana Landini Aleotti's net worth is estimated at $7.5 billion as of 15 Oct 2026, according to Forbes Real-Time Billionaires. Massimiliana Landini Aleotti inherited control of Menarini, the Florence pharmaceutical group built by her late husband Alberto Aleotti, which she owns with her two children.

Industry
Healthcare
Age
84
Self-made
No, inherited
City
Florence
Source of wealth
Menarini pharmaceuticals

Latest estimate

$7.5B

As of 15 Oct 2026, Forbes Real-Time Billionaires

-$1.7B

-18.5%

vs Jan 2026

History
Healthcare setting, the industry behind this fortune
Healthcare, the industry behind this fortune. Illustration, not a photo of Massimiliana Landini Aleotti.

Massimiliana's net worth over time

3 dated estimates since 2019

$0 $2B $5B $7B $10B 2019 2021 2023 2025 $7.4B, 2019, Forbes $9.2B, 2026, Forbes $7.5B, 15 Oct 2026, Forbes Real-Time Billionaires
As ofNet worthSource
15 Oct 2026$7.5B Forbes Real-Time Billionaires
2026$9.2B Forbes
2019$7.4B Forbes

How Massimiliana built the fortune

Massimiliana Landini Aleotti's wealth comes from Menarini, one of the largest privately owned pharmaceutical companies in Europe. The business was founded in Naples in 1886 and later moved its headquarters to Florence. Its modern growth is owed to her husband, Alberto Sergio Aleotti, who joined the company in the 1960s, took control of it and over the following decades turned a mid sized Italian drug maker into an international group.

Aleotti expanded Menarini through licensing deals, in which it sold medicines developed by other companies in its markets, and through acquisitions. A key step came in 1992, shortly after German reunification, when Menarini bought Berlin-Chemie, a former East German pharmaceutical producer. Berlin-Chemie became the platform for a large business in Germany and across central and eastern Europe. Menarini later built operations in Asia and Latin America and today sells its products in well over one hundred countries.

When Alberto Aleotti died in 2014, ownership of the group passed to Massimiliana and their children, Lucia and Alberto Giovanni Aleotti. The family has kept the company private, with the children taking the most visible roles in its governance, and has continued to invest in research and acquisitions. The value of their holding reflects Menarini's steady sales of established medicines combined with newer specialist products.

Staying private has shaped the business. Without public shareholders, Menarini can take a long view on research spending and acquisitions and does not publish quarterly results. The family has repeatedly said it intends to keep the company independent, even as consolidation in the pharmaceutical industry has led many mid sized European drug makers to sell to larger rivals.

Companies and holdings

The family's main asset is the Menarini Group, headquartered in Florence. Its activities include:

  • prescription medicines in cardiology, gastroenterology, pain and inflammation, respiratory and other areas
  • over the counter and consumer health products
  • oncology, strengthened by the acquisition of the US biotech company Stemline Therapeutics in 2020
  • diagnostics, through Menarini Diagnostics and its specialist businesses
  • Berlin-Chemie, the group's large German subsidiary

Menarini runs manufacturing plants in Italy, Germany, Spain and other countries, and maintains its own research centres. Lucia Aleotti and Alberto Giovanni Aleotti serve on the board as representatives of the shareholders, while day to day management is entrusted to professional executives. Massimiliana's role is that of a co-owner rather than an operating manager.

Because the shares are not traded, the value of the family's stake can only be estimated from Menarini's reported revenue and profits and from the prices paid for comparable companies. The group's turnover runs to several billion euros a year, and a large share of it comes from outside Italy.

Early life and career

Massimiliana Landini was born in August 1942 and married Alberto Aleotti, who was building his career in the pharmaceutical industry. Over the following decades the couple settled in Florence, where Menarini had become one of the city's most important employers. Unlike her husband, she did not take an executive role in the business, and little detail about her own education or early career has been made public.

Her place in the company changed after her husband's death, when the inheritance gave her and her children shared ownership of the entire group. Since then the family has worked to maintain continuity in a company that had been closely identified with its patriarch. Lucia, who had already been active in the business, became one of its leading voices, and Alberto Giovanni took on a prominent board role, while Massimiliana remained largely out of public view.

Philanthropy and public life

The family's best known philanthropic and scientific vehicle is the Fondazione Menarini, established in 1976. It organises international medical conferences and educational programmes for doctors and researchers and publishes scientific material, contributing to continuing medical education in Italy and abroad. Menarini is also known in Italy for its long running series of art publications, distributed to doctors, and for support of cultural initiatives in Florence.

Massimiliana herself avoids publicity and rarely appears in the media. Public statements about the group and its social commitments are made by her children or by company executives, and her personal giving is not documented in detail.

Key dates

  1. 1886 Menarini is founded in Naples.
  2. 1942 Massimiliana Landini is born in August.
  3. 1976 The Fondazione Menarini is established.
  4. 1992 Menarini acquires the German drug maker Berlin-Chemie.
  5. 2014 Her husband Alberto Aleotti dies, and ownership passes to her and their two children.
  6. 2020 Menarini acquires the US oncology company Stemline Therapeutics.

Sources

The description is written by BillionaireList editors from public facts. How estimates are made: methodology.

About Massimiliana Landini Aleotti, common questions

How much is Massimiliana Landini Aleotti worth?
Massimiliana Landini Aleotti's net worth is estimated at $7.5 billion as of 15 Oct 2026, according to Forbes Real-Time Billionaires. That places Massimiliana at number 527 in the BillionaireList ranking.
How did Massimiliana Landini Aleotti make her money?
She inherited a share of the Menarini pharmaceutical group after the death of her husband, Alberto Aleotti, in 2014. He had built the Florence company into a large international drug maker.
Who owns Menarini?
Menarini is privately owned by the Aleotti family: Massimiliana Landini Aleotti and her children Lucia and Alberto Giovanni Aleotti.
What does Menarini make?
Menarini makes prescription drugs in areas such as cardiology, gastroenterology and oncology, along with consumer health products and diagnostics.

Request a correction

Send a public source that shows a different fact. We confirm your email, check the source and update the profile. A removal request needs no source: the profile is hidden at once.